Publicaciones
-
Bukchin, A, Sanchez-Navarro, M, Carrera, A, Teixido, M, Carcaboso AM, Giralt, E and Sosnik, A.
Amphiphilic Polymeric Nanoparticles Modified with a Retro-Enantio Peptide Shuttle Target the Brain of Mice
CHEMISTRY OF MATERIALS . 32(18): 7679-7693. Nº de citas: 17
-
Wiese M, Hamdan FH, Kubiak K, Diederichs C, Gielen GH, Nussbaumer G, Carcaboso AM, Hulleman E, Johnsen SA and Kramm CM.
Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells
CELL DEATH & DISEASE . 11(8): 673-673. Nº de citas: 40
-
Castillo H, Monterrubio C, Pascual-Pastó G, Gomez-Gonzalez S, Garcia-Dominguez DJ, Hontecillas-Prieto L, Resa-Parés C, Burgeño-Sandoval V, Paco-Mercader S, Gene-Olaciregui N, Vilà-Ubach M, Restrepo-Perdomo C, Cuadrado-Vilanova M, Balaguer-Lluna L, Pérez-Jaume S, Castañeda-Heredia A, Santa-María López V, Roldan-Molina M, Suñol M, de Alava E, Mora J, Lavarino C and Carcaboso AM.
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution
JOURNAL OF CONTROLLED RELEASE . 324: 440-449. Nº de citas: 6
-
Chen KY, Bush K, Klein RH, Cervantes V, Lewis N, Naqvi A, Carcaboso AM, Lechpammer M and Knoepfler PS.
Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling
Communications Biology . 3(1): 363-363. Nº de citas: 32
-
Bossacoma F, Cuadrado-Vilanova M, Vinent-Genestar J, Correa MG, Gavrus D, Castillo H, Català-Mora J, Mora J, Schaiquevich P, Chantada G and Carcaboso AM.
Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection
OPHTHALMIC GENETICS . 41(4): 397-400. Nº de citas: 1
-
Meel MH, de Gooijer MC, Metselaar DS, Sewing ACP, Zwaan K, Waranecki P, Breur M, Buil LCM, Lagerweij T, Wedekind LE, Twisk JWR, Koster J, Hashizume R, Raabe EH, Carcaboso AM, Bugiani M, Phoenix TN, van Tellingen O, van Vuurden DG, Kaspers GJL and Hulleman E.
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
CLINICAL CANCER RESEARCH . 26(13): 3319-3332. Nº de citas: 42
-
Deligne C, Hachani J, Duban-Deweer S, Meignan S, Leblond P, Carcaboso AM, Sano Y, Shimizu F, Kanda T, Gosselet F, Dehouck MP and Mysiorek C.
Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance
Fluids and Barriers of the CNS . 17(1): 37-37. Nº de citas: 32
-
Galardi A, Colletti M, Lavarello C, Paolo VD, Mascio P, Russo I, Cozza R, Romanzo A, Valente P, Vito R, Pascucci L, Peinado H, Carcaboso AM, Petretto A, Locatelli F and Giannatale AD.
Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding
Cancers . 12(6): . Nº de citas: 35
-
Chaves C, Declèves X, Taghi M, Menet MC, Lacombe J, Varlet P, Gene-Olaciregui N, Carcaboso AM and Cisternino S.
Characterization of the Blood-Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine Glioma
Pharmaceutics . 12(5): . Nº de citas: 19
-
Winter U, Ganiewich D, Ottaviani D, Zugbi S, Aschero R, Sendoya JM, Cafferata EG, Mena M, Sgroi M, Sampor C, Lubieniecki F, Fandiño A, Abba MC, Doz F, Podhjacer O, Carcaboso AM, Letouzé E, Radvanyi F, Chantada G, Llera AS and Schaiquevich P.
Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma
JAMA OPHTHALMOLOGY . 138(5): 569-574. Nº de citas: 19